London, United Kingdom

Neil Mathews

USPTO Granted Patents = 6 



Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 41(Granted Patents)


Location History:

  • Welwyn, GB (2002 - 2004)
  • London, GB (2004 - 2017)
  • Stevenage, GB (2018)

Company Filing History:


Years Active: 2002-2018

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Neil Mathews

Introduction

Neil Mathews is a prominent inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating respiratory syncytial virus (RSV) infections. With a total of six patents to his name, Mathews has established himself as a key figure in medical innovation.

Latest Patents

Mathews' latest patents include groundbreaking work on spiro-indolines and benzimidazoles. These compounds are designed to act as inhibitors of RSV, providing potential treatment and prophylaxis for this viral infection. The detailed chemical formulations outlined in his patents demonstrate his expertise in medicinal chemistry and his commitment to addressing critical health challenges.

Career Highlights

Throughout his career, Mathews has worked with notable companies such as SmithKline Beecham Corporation and Reviral Limited. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research and development.

Collaborations

Mathews has collaborated with esteemed colleagues, including Paul John Beswick and Ian B Campbell. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of medical breakthroughs.

Conclusion

Neil Mathews is a distinguished inventor whose work in the pharmaceutical industry has the potential to impact public health significantly. His innovative patents and collaborations reflect his dedication to advancing medical science and improving treatment options for viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…